GO:0043647 inositol phosphate metabolic process: Signaling Hub, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043647 describes the chemical reactions and pathways involving inositol phosphate, a cyclohexanehexol bearing one or more phosphate groups.
• Inositol phosphates act as cellular signals, metabolic messengers, and molecular glues that coordinate metabolic adaptability [1,2].
• Key enzymes include ITPK1, IPK1, IPMK, and IMPA1/2, which interconvert inositol polyphosphates and buffer diphosphoinositol phosphate levels.
• Inositol phosphates dynamically enhance the stability, solubility, and catalytic activity of mTOR, linking this pathway to growth control.
• Dysregulation of inositol phosphate metabolism is implicated in cancer, neurodegeneration, and metabolic disorders [1,6].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of this pathway in human cells.
Description
Inositol phosphate metabolic process (GO:0043647) encompasses the chemical reactions and pathways involving inositol phosphate, defined as 1,2,3,4,5,6-cyclohexanehexol with one or more phosphate groups attached. This ontology term captures a dense network of interconversions that generate soluble inositol polyphosphates (IPs) and pyrophosphorylated inositol phosphates (PP-IPs), which serve as signaling molecules, metabolic messengers, and cofactors in eukaryotic cells [1,6]. The pathway is evolutionarily conserved and intersects with phosphoinositide signaling, insulin action, and nutrient sensing [4,5]. For researchers, GO:0043647 matters because inositol phosphates are not merely metabolic intermediates; they act as molecular glues that stabilize protein complexes and modulate enzyme activity. For example, inositol phosphates dynamically enhance the stability, solubility, and catalytic activity of mTOR, a central regulator of cell growth and metabolism. The pathway also includes an ATP-responsive metabolic cassette comprised of ITPK1 and IPK1 that buffers diphosphoinositol phosphate levels, highlighting its role in energy homeostasis. Understanding this process requires integrating enzymology, structural biology, and cellular physiology. Historical and methodological advances have made inositol phosphate research tractable, from radiolabeling to modern mass spectrometry and genetic perturbation. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0043647, its genes, regulation, disease links, and experimental models.
inositol phosphate metabolic process At A Glance
| GO ID | GO:0043647 |
|---|---|
| GO term | inositol phosphate metabolic process |
| Ontology | biological_process |
| Synonym | inositol phosphate metabolism; myo-inositol phosphate metabolic process; myo-inositol phosphate metabolism |
| Definition | The chemical reactions and pathways involving inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached. |
| Major function | Production and interconversion of soluble inositol phosphates that act as signals, metabolic messengers, and molecular glues [1,2]. |
| Key enzymes | ITPK1, IPK1, IPMK, IMPA1, IMPA2, and related kinases/phosphatases [3,6]. |
| Subcellular context | Cytosol and nucleus, with dynamic association to membranes and protein complexes [2,5]. |
| Disease relevance | Cancer, neurodegeneration, metabolic disorders, and insulin signaling defects [1,4,6]. |
What Is GO:0043647?
GO:0043647, inositol phosphate metabolic process, is defined by QuickGO as the chemical reactions and pathways involving inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached. In practice, this term covers the biosynthesis, interconversion, and degradation of soluble inositol phosphates, including inositol trisphosphate (IP3), inositol tetrakisphosphate (IP4), inositol pentakisphosphate (IP5), inositol hexakisphosphate (IP6), and their pyrophosphorylated derivatives [1,5]. It is a biological process ontology term that excludes phosphatidylinositol lipids, which are covered by separate GO terms.
Why Is inositol phosphate metabolic process Important in Cell Biology?
GO:0043647 is important because inositol phosphates are central to cellular signal transduction and metabolic adaptability. They serve as second messengers in insulin action and calcium signaling [4,5], as molecular glues that stabilize protein complexes, and as dynamic regulators of mTOR, a master growth controller. The pathway also buffers diphosphoinositol phosphates in response to ATP availability, linking energy status to signaling. Consequently, perturbing this process has broad consequences for cell growth, stress responses, and disease.
• Inositol phosphates act as cellular signals and second messengers in insulin action and calcium mobilization [4,5].
• They function as molecular glues that enhance protein stability and complex assembly.
• Inositol phosphates dynamically enhance mTOR stability, solubility, and catalytic activity.
• The ITPK1-IPK1 metabolic cassette buffers diphosphoinositol phosphate levels in an ATP-responsive manner.
• Myo-inositol phosphate synthase improves heat stress tolerance via ethylene-mediated modulation of chlorophyll content and photosynthetic efficiency.
• Dysregulation is linked to cancer, neurodegeneration, and metabolic disorders [1,6].
• The pathway is conserved from plants to humans, enabling cross-species studies.
• It provides targets for therapeutic intervention in insulin resistance and cancer [1,4].
• Methodological advances have made inositol phosphate research accessible to modern labs.
• CRISPR models allow causal testing of specific enzymes in human cells.
What Happens During inositol phosphate metabolic process?
Biosynthesis of inositol phosphates from myo-inositol
In simple terms: The cell starts with myo-inositol and adds phosphate groups step by step to build signaling molecules.
The pathway begins with myo-inositol, which is phosphorylated by specific kinases to generate inositol monophosphate, then inositol trisphosphate, and higher inositol polyphosphates. In plants, myo-inositol phosphate synthase improves heat stress tolerance by ethylene-mediated modulation of chlorophyll content and photosynthetic efficiency, illustrating the pathway's role in stress responses. In mammalian cells, the sequential phosphorylation is carried out by enzymes such as ITPK1 and IPMK, which generate IP4, IP5, and IP6 [3,6]. These soluble inositol phosphates serve as precursors for pyrophosphorylated derivatives and as signaling molecules.
Interconversion and pyrophosphorylation by ITPK1 and IPK1
In simple terms: Enzymes can add or remove phosphates to convert one inositol phosphate into another, including adding pyrophosphate groups.
An ATP-responsive metabolic cassette comprised of inositol tris/tetrakisphosphate kinase 1 (ITPK1) and inositol pentakisphosphate 2-kinase (IPK1) buffers diphosphoinositol phosphate levels. ITPK1 phosphorylates inositol trisphosphate and tetrakisphosphate, while IPK1 phosphorylates inositol pentakisphosphate to produce inositol hexakisphosphate and related pyrophosphorylated species. This interconversion is sensitive to ATP availability, linking energy status to inositol phosphate signaling. The resulting diphosphoinositol phosphates can act as molecular glues and regulate protein function.
Degradation and recycling by phosphatases
In simple terms: Phosphatases remove phosphate groups to recycle inositol or terminate signals.
Inositol phosphate levels are also controlled by phosphatases such as IMPA1 and IMPA2, which dephosphorylate inositol phosphates to regenerate myo-inositol or lower-order phosphates. This degradation is essential for terminating signals and maintaining metabolic homeostasis. The balance between kinase and phosphatase activities determines the steady-state levels of each inositol phosphate species, which in turn influences downstream processes such as mTOR regulation.
Signaling and molecular glue functions
In simple terms: Inositol phosphates can stick to proteins and help them work better or hold complexes together.
Inositol phosphates act as cellular signals and molecular glues that dynamically enhance the stability, solubility, and catalytic activity of mTOR. They also participate in insulin second messenger pathways, mediating metabolic responses. The myo-inositol metabolites as cellular signals have been recognized for decades as key regulators of diverse processes. These functions depend on the precise phosphorylation state of the inositol ring, which is controlled by the metabolic enzymes described above [1,2].
Key Genes Involved in GO:0043647 inositol phosphate metabolic process
The following genes encode enzymes and regulators that directly participate in or control inositol phosphate metabolic process (GO:0043647).
| Gene | Major Role | Research Relevance |
|---|---|---|
| ITPK1 | Inositol tris/tetrakisphosphate kinase; buffers diphosphoinositol phosphate levels | ATP-responsive metabolic cassette; target for metabolic studies |
| IPK1 | Inositol pentakisphosphate 2-kinase; produces IP6 and pyrophosphorylated species | Key enzyme in inositol phosphate interconversion |
| IPMK | Inositol polyphosphate multikinase; generates IP4 and IP5 | Links inositol phosphate synthesis to growth signaling |
| IMPA1 | Inositol monophosphatase; dephosphorylates inositol phosphates | Recycling and signal termination |
| IMPA2 | Inositol monophosphatase; dephosphorylates inositol phosphates | Candidate for neurological and metabolic studies |
| IP6K1 | Inositol hexakisphosphate kinase; produces PP-IP5 | Regulates diphosphoinositol phosphate levels |
| IP6K2 | Inositol hexakisphosphate kinase; produces PP-IP5 | Role in stress responses and cancer |
| PPIP5K1 | Diphosphoinositol pentakisphosphate kinase | Generates high-energy inositol pyrophosphates |
| PPIP5K2 | Diphosphoinositol pentakisphosphate kinase | Regulates phosphate homeostasis |
| MINPP1 | Multiple inositol polyphosphate phosphatase | Degrades IP6 and higher phosphates |
| INPP5A | Inositol polyphosphate 5-phosphatase | Terminates IP3 signaling |
| INPP5B | Inositol polyphosphate 5-phosphatase | Regulates phosphoinositide and inositol phosphate pools |
| OCRL | Inositol polyphosphate 5-phosphatase | Mutations cause Lowe syndrome |
| SYNJ1 | Synaptojanin 1; inositol 5-phosphatase | Neurodegeneration and synaptic function |
| MIPS1 | Myo-inositol phosphate synthase | Heat stress tolerance in plants |
| mTOR | Serine/threonine kinase regulated by inositol phosphates | Central growth controller; inositol phosphate-dependent activity |
| IPPK | Inositol pentakisphosphate 2-kinase | Produces IP6; links to DNA repair |
| ITPKA | Inositol trisphosphate 3-kinase | Regulates IP4 levels in neurons |
How Is inositol phosphate metabolic process Regulated?
Inositol phosphate metabolic process is regulated at multiple levels. The ITPK1-IPK1 metabolic cassette is ATP-responsive, meaning that cellular energy status directly influences diphosphoinositol phosphate buffering. Inositol phosphates dynamically enhance the stability, solubility, and catalytic activity of mTOR, creating a feedback loop between inositol phosphate metabolism and growth signaling. Insulin second messengers derived from inositol phosphates mediate metabolic responses, linking the pathway to hormonal regulation. Additionally, myo-inositol metabolites act as cellular signals that can be modulated by extracellular cues. In plants, myo-inositol phosphate synthase improves heat stress tolerance via ethylene-mediated modulation of chlorophyll content and photosynthetic efficiency, indicating environmental regulation. Overall, the pathway is controlled by the balance of kinase and phosphatase activities, substrate availability, and energy charge [1,6].
inositol phosphate metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IP6K1 | Cancer and metabolic disorders | Knockout and overexpression in cancer cell lines |
| IP6K2 | Stress responses and cancer | Point-mutation and knockout models |
| OCRL | Lowe syndrome | Patient-derived fibroblasts and knock-in models |
| SYNJ1 | Neurodegeneration | Neuronal knockout and knock-in models |
| ITPK1 | Metabolic adaptability | ATP-responsive knockout and rescue models |
Cancer and cell growth
Inositol phosphate metabolism is frequently dysregulated in cancer because it controls mTOR activity and cell growth. Inositol phosphates dynamically enhance the stability, solubility, and catalytic activity of mTOR, a central oncogenic driver. Enzymes such as IP6K1 and IP6K2 produce pyrophosphorylated inositol phosphates that influence cell survival and stress responses. Targeting these enzymes may offer therapeutic opportunities in cancers with aberrant mTOR signaling [1,7].
Neurodegeneration and synaptic function
Inositol phosphates act as cellular signals in neurons, and their dysregulation is linked to neurodegeneration [5,6]. SYNJ1 (synaptojanin 1) is an inositol 5-phosphatase involved in synaptic vesicle recycling, and its dysfunction is associated with neurodegenerative phenotypes. OCRL mutations cause Lowe syndrome, a disorder with neurological and renal features, highlighting the importance of inositol phosphate turnover. The historical perspective of inositol phosphate research underscores its long-standing connection to neuronal signaling.
Metabolic disorders and insulin resistance
Inositol phosphates serve as insulin second messengers, mediating metabolic responses to the hormone. Dysregulation of this pathway can contribute to insulin resistance and metabolic disorders [1,4]. The ATP-responsive ITPK1-IPK1 cassette buffers diphosphoinositol phosphate levels, linking energy status to metabolic adaptability. Therefore, enzymes in this pathway are candidate targets for metabolic disease research [1,3].
From inositol phosphate metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ITPK1 loss alter diphosphoinositol phosphate buffering? | ITPK1 knockout cell line |
| Does a specific point mutation in IPK1 affect IP6 production? | IPK1 point-mutation knock-in |
| Can tagged IPMK reveal its interactome? | Endogenous tagged knock-in |
| Does overexpression of IP6K1 drive mTOR activation? | IP6K1 overexpression cell line |
| Is IMPA1 required for inositol recycling? | IMPA1 knockout and rescue |
| Which genes buffer ATP-dependent inositol phosphates? | CRISPR library screening |
How to Study the inositol phosphate metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS | Quantification of inositol phosphate species | Profiling pathway changes after CRISPR perturbation |
| CRISPR knockout | Loss-of-function effects | Testing ITPK1 or IPK1 requirement |
| Point-mutation knock-in | Specific residue function | Validating catalytic mutants |
| Overexpression | Gain-of-function effects | Testing IP6K1-driven mTOR activation |
| Co-immunoprecipitation | Protein-protein interactions | Identifying molecular glue targets |
| Thermal shift assay | Protein stability | Measuring inositol phosphate-dependent mTOR stability |
| Enzyme activity assay | Kinase/phosphatase activity | Characterizing ITPK1-IPK1 cassette |
| RNA-seq | Transcriptional changes | Assessing pathway-wide responses |
Mass spectrometry and chromatographic profiling
Mass spectrometry coupled with chromatographic separation is a primary method to quantify inositol phosphate species. Historical methods have evolved from radiolabeling to modern LC-MS/MS, enabling precise measurement of IP3, IP4, IP5, IP6, and pyrophosphorylated derivatives. These methods are essential to determine how genetic perturbations alter the inositol phosphate metabolome.
Genetic perturbation with CRISPR
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of specific enzymes in the pathway. For example, knocking out ITPK1 or IPK1 can reveal their roles in buffering diphosphoinositol phosphates. Overexpression of IP6K1 can test whether increased pyrophosphorylation enhances mTOR activity. These approaches are complemented by rescue experiments to confirm specificity.
Biochemical enzyme assays
In vitro kinase and phosphatase assays using recombinant enzymes measure catalytic activity, substrate specificity, and regulation by ATP or other cofactors. The ITPK1-IPK1 cassette was characterized using such assays, demonstrating ATP-responsive buffering of diphosphoinositol phosphates. These assays are critical for validating point mutations identified in disease or functional screens.
Protein interaction and molecular glue assays
Inositol phosphates act as molecular glues that stabilize protein complexes, so interaction assays such as co-immunoprecipitation, pull-down, and proximity labeling can identify their protein partners. For mTOR, inositol phosphates dynamically enhance stability, solubility, and catalytic activity, which can be monitored by thermal shift and activity assays. These methods link metabolic state to protein function [2,7].
How CRISPR Can Be Used to Study GO:0043647 inositol phosphate metabolic process
Knockout
CRISPR knockout of genes such as ITPK1, IPK1, IPMK, or IMPA1 creates loss-of-function models to test their roles in inositol phosphate metabolic process. For example, knocking out ITPK1 can reveal its contribution to buffering diphosphoinositol phosphate levels. Knockout of IP6K1 or IP6K2 can assess their impact on mTOR activity and cell growth. These models are foundational for causal inference in the pathway.
Point Mutation
Point-mutation knock-in allows precise testing of catalytic residues or regulatory phosphorylation sites. For instance, mutating the ATP-binding site of ITPK1 can distinguish its kinase activity from scaffolding functions. Point mutations in IPK1 can reveal residues critical for IP6 production. These models are valuable for dissecting molecular mechanisms without confounding effects of complete protein loss.
Knock-in
Knock-in of tagged versions of enzymes such as IPMK or ITPK1 enables endogenous expression and interaction studies. Tagged knock-in can be used for proximity labeling or co-immunoprecipitation to identify molecular glue targets. Knock-in of disease-associated mutations, such as those in OCRL, can model Lowe syndrome in relevant cell types. This approach preserves native regulation and expression levels.
Overexpression
Overexpression of genes like IP6K1 or IPMK can test gain-of-function effects on inositol phosphate levels and downstream signaling. For example, overexpression of IP6K1 may increase pyrophosphorylated inositol phosphates and enhance mTOR activity. Overexpression of myo-inositol phosphate synthase in plants improves heat stress tolerance, demonstrating cross-species applicability. These models complement knockout studies by revealing sufficiency.
How EDITGENE Supports inositol phosphate metabolic process Research
Researchers studying inositol phosphate metabolic process-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as altered mTOR signaling, metabolic adaptability, or disease progression. CRISPR-based models provide the gold standard for such causal testing, enabling precise genetic perturbations in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for inositol phosphate metabolic process research.
Frequently Asked Questions About inositol phosphate metabolic process
What is inositol phosphate metabolic process?
It is the biological process defined by GO:0043647 that includes the chemical reactions and pathways involving inositol phosphate, a cyclohexanehexol with one or more phosphate groups attached.
What genes are involved in inositol phosphate metabolic process?
Key genes include ITPK1, IPK1, IPMK, IMPA1, IMPA2, IP6K1, IP6K2, PPIP5K1, PPIP5K2, MINPP1, INPP5A, INPP5B, OCRL, SYNJ1, and MIPS1 [3,6,8].
Why is inositol phosphate metabolism important for cells?
It produces signaling molecules and molecular glues that regulate mTOR stability and activity, insulin responses, and metabolic adaptability [1,4,7].
How does ITPK1 regulate diphosphoinositol phosphate levels?
ITPK1, together with IPK1, forms an ATP-responsive metabolic cassette that buffers diphosphoinositol phosphate levels.
What diseases are linked to inositol phosphate metabolism?
Cancer, neurodegeneration, Lowe syndrome, and metabolic disorders have been linked to dysregulation of this pathway [1,6].
How can I study inositol phosphate metabolic process in the lab?
Common methods include LC-MS/MS profiling, CRISPR knockout or knock-in, enzyme activity assays, and protein interaction assays [2,3,6].
What is the role of inositol phosphates in mTOR signaling?
Inositol phosphates dynamically enhance the stability, solubility, and catalytic activity of mTOR.
Can CRISPR be used to study inositol phosphate metabolism?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of specific enzymes in the pathway [3,7].
What is the ATP-responsive metabolic cassette in inositol phosphate metabolism?
It is a complex of ITPK1 and IPK1 that buffers diphosphoinositol phosphate levels in response to ATP availability.
How does myo-inositol phosphate synthase help plants?
It improves heat stress tolerance by ethylene-mediated modulation of chlorophyll content and photosynthetic efficiency.
Conclusion
GO:0043647, inositol phosphate metabolic process, is a central biological process that generates soluble inositol phosphates with diverse signaling and metabolic functions. From buffering diphosphoinositol phosphates via the ITPK1-IPK1 cassette to dynamically regulating mTOR, this pathway influences cell growth, energy homeostasis, and disease [3,7]. Its dysregulation is implicated in cancer, neurodegeneration, and metabolic disorders, making it a rich area for therapeutic research [1,6]. Modern CRISPR tools and analytical methods now allow precise causal dissection of this pathway. By combining knockout, point-mutation, knock-in, and overexpression models with mass spectrometry and interaction assays, researchers can uncover how specific enzymes contribute to inositol phosphate metabolism and related phenotypes [2,6]. EDITGENE provides comprehensive services to accelerate such discoveries.
References
- 1. Tu-Sekine B et al.. 2022. The Inositol Phosphate System-A Coordinator of Metabolic Adaptability.. Int J Mol Sci 23(12) PMID: 35743190
- 2. Seaton-Terry A et al.. 2026. Phosphoinositides and inositol phosphates as molecular glues.. FEBS Lett 600(17):2437-2450 PMID: 42317063
- 3. Whitfield H et al.. 2020. An ATP-responsive metabolic cassette comprised of inositol tris/tetrakisphosphate kinase 1 (ITPK1) and inositol pentakisphosphate 2-kinase (IPK1) buffers diphosphosphoinositol phosphate levels.. Biochem J 477(14):2621-2638 PMID: 32706850
- 4. Strålfors P. 1997. Insulin second messengers.. Bioessays 19(4):327-35 PMID: 9136630
- 5. Downes CP et al.. 1990. myo-inositol metabolites as cellular signals.. Eur J Biochem 193(1):1-18 PMID: 2171926
- 6. Shears SB. 2020. A Short Historical Perspective of Methods in Inositol Phosphate Research.. Methods Mol Biol 2091:1-28 PMID: 31773566
- 7. Rameh LE et al.. 2025. Inositol phosphates dynamically enhance stability, solubility, and catalytic activity of mTOR.. J Biol Chem 301(2):108095 PMID: 39706276
- 8. Sharma N et al.. 2023. Myo-inositol phosphate synthase improves heat stress tolerance by ethylene-mediated modulation of chlorophyll content and photosynthetic efficiency.. Protoplasma 260(4):1097-1107 PMID: 36602620
